Microvascular Features of Treated Retinoblastoma Tumors in Children Assessed Using OCTA

Ophthalmic Surg Lasers Imaging Retina. 2019 Dec 1;51(1):43-49. doi: 10.3928/23258160-20191211-06.

Abstract

Background and objective: To describe the microvascular features of treated, clinically regressed, or reactivated retinoblastoma lesions using an investigational portable optical coherence tomography angiography (OCTA) system.

Patients and methods: Single-center, prospective, cross-sectional, consecutive case-series of children with previously treated retinoblastoma who underwent portable OCTA of posterior retinoblastoma lesions.

Results: Eight tumors from seven eyes of five children with retinoblastoma were included. Tumors with types 1 (calcified remnant, n = 3), 2 (non-calcified remnant, n = 1), and 3 (both calcified and noncalcified remnants, n = 1) regression revealed persistent intrinsic superficial vasculature on OCTA (five of five lesions; 100%). Lesions with type 4 regression (atrophic scar, n = 2) had complete vascular flow voids in the involved retina and underlying choriocapillaris. A reactivated tumor (n = 1) showed a distinct area of vascularity with prominent feeder/draining vessels.

Conclusions: OCTA revealed that significant vascularity exists in inactive retinoblastoma lesions. Dilated feeder vessels may suggest continued disease activity. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:43-49.].

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Fluorescein Angiography*
  • Humans
  • Hyperthermia, Induced
  • Infant
  • Infusions, Intra-Arterial
  • Male
  • Microcirculation / physiology
  • Prospective Studies
  • Regional Blood Flow
  • Retinal Neoplasms / diagnostic imaging
  • Retinal Neoplasms / drug therapy
  • Retinal Neoplasms / physiopathology*
  • Retinal Vessels / diagnostic imaging
  • Retinal Vessels / pathology*
  • Retinoblastoma / diagnostic imaging
  • Retinoblastoma / drug therapy
  • Retinoblastoma / physiopathology*
  • Tomography, Optical Coherence*

Substances

  • Antineoplastic Agents